Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules

Fig. 2

Cytological cyclin D1 immunostaining of thyroid neoplasms. a Cytological features of adenomatous goiter and papillary thyroid carcinoma using cyclin D1 immunostaining and Papanicolaou stain. Note absence of cyclin D1 immunostaining in adenomatous goiter and positive nuclear staining for cyclin D1 in papillary thyroid carcinoma. b Cytology of cyclin D1 immunolabeling with different types of thyroid neoplasms (n = 31). c There is correlation between cyclin D1- nuclear expression and tumor malignancy in thyroid neoplasm cells

Back to article page